$59.74
Today
as of Jul 22, 16:46 ET
Last 30 days
Recent Press Releases & News
BRKR: What does Argus have to say about BRKR?
Bruker Acquires Noscendo's Disqver Clinical Metagenomics Platform
Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood
Overview
52-week range
$29
$63
90% of range
Avg surprise (last 3)
+11.3%
Avg reaction (last 2)
+7.3%
100% positive
Latest IV / EM
74%
EM ±16.8% · $60 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $0.31 | $0.23 | +34.8% | -34.0% | +11.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.41 | — | — | — | — | financials |
| Mon Aug 4, 2025 | Jun/2025 | $0.32 | $0.33 | -3.0% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $0.47 | $0.46 | +2.2% | — | +3.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.27 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.05 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.35 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.60 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.39 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 3, 2026 | Jun/2026 | OTHER | $0.38 | $0.32 | +18.8% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $444M | — | $481M | $440M | $410M | — | $446M | $416M |
| Gross profit | $380M | — | $379M | $358M | $391M | — | $419M | $385M |
| Operating income | $10M | — | $-52M | $12M | $32M | — | $68M | $48M |
| Net income | $14M | — | $-60M | $8M | $17M | — | $41M | $8M |
| EPS (diluted) | $0.02 | — | $-0.41 | $0.05 | $0.11 | — | $0.27 | $0.05 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $133M | $299M | $293M | $92M | $184M | $183M | $148M | $170M |
| Inventory | $1.12B | $1.09B | $1.20B | $1.22B | $1.12B | $1.07B | $1.22B | $1.18B |
| Total current assets | $2.10B | $2.21B | $2.35B | $2.16B | $2.11B | $2.05B | $2.19B | $2.15B |
| Total assets | $6.13B | $6.24B | $6.43B | $6.34B | $5.93B | $5.81B | $6.11B | $5.90B |
| Long-term debt | $1.66B | $1.85B | $1.98B | $2.38B | $2.08B | $2.06B | $2.26B | $2.13B |
| Total liabilities | — | — | — | — | — | — | $4.27B | $4.08B |
| Total equity | — | — | $2.43B | — | — | $1.78B | $1.81B | $1.79B |